• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Endocrinology

Study examines early re-transition rate for young transgender children

byVincent SoandAlex Gipsman, MD
July 14, 2022
in Endocrinology, Pediatrics, Psychiatry
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Rates of early re-transition were low (7.3%) following early transition for youth aged 3-12 years old for approximately 5 years after initial social transition.

2. Serious limitations of the study include its high risk for selection bias, use of pronouns at a single visit to define gender, and a follow up period of only 5 years.

Evidence Rating Level: 4 (Below Average)

Study Rundown: The number of transgender children has increased significantly in the United States in recent years. Some feel that early transition for gender-diverse youth may minimize childhood distress, although concerns exist surrounding the possibility of retransition where youth may no longer identify as transgender or gender-diverse. This study examined the rate of early retransition (within 5 years of initial transition) among children who transitioned at a young age (mean 6.5 years). Subjects were part of The Trans Youth Project, which is a group of children between age 3 and 12 years who made a complete social transition to the opposite gender. Of the study cohort, 7.3% re-transitioned within 5 years of initial social transition. The study carries serious shortcomings that limit the results and their generalizability. The authors only investigated rates of re-transition for 5 years following initial transition and are therefore not helpful in discerning rates of re-transition past that timeframe. Furthermore, the children and parents who volunteer to be part of the Trans Youth Project may have important differences from other populations that affect rates of re-transition (selection bias). Finally, the study relied on the use of preferred pronouns at a single encounter to define a child’s gender. Overall, the study suggests that in young transgender children, the rate of re-transition is low for the first 5 years following initial transition, although more robust studies are required to confirm this finding.

Click here to read the article in PEDIATRICS

Click here to read an accompanying editorial

RELATED REPORTS

Adolescents and their caregivers report benefits, challenges, and recommendations regarding gender-affirming care in primary care

The 2 Minute Medicine Podcast Episode 8

Gender-affirming hormones improve psychosocial functioning in transgender youth

In Depth [Longitudinal Study]: A total of 317 socially transitioned transgender children were included in this study from the Trans Youth Project aged 3 to 12 years of age between July 2013 and December 2017. Of the included participants, 208 were initially transgender girls and 109 were initially transgender boys. Demographic information included 65.6% of participants assigned male sex at birth, mean age of 6.5 years for first transition, and average of 5.4 years since first transition at time of data collection. Of the youth in the study, 37 (11.7%) had initiated gender-affirming hormone therapy prior to enrolling in the study. The results suggested a rate of retransition of 7.3% on average of 5.37 (SD 1.74) years after initial social transition, with 94.0% living as binary transgender youth. Additionally, 1.3% re-transitioned twice, 3.5% were living as non-binary, and 2.5% were using pronouns associated with their sex at birth. The majority (69%) of children were  white, non-Hispanic and 66% of participants had an annual household income greater than $75,000. Post hoc analysis suggests low rates of retransition in children who transitioned prior to age 6 were more likely to be currently living as cisgender than children who transitioned later, where the younger group had a higher rate of retransition (p=0.02 on Fisher exact test), although the rate was low in both groups (n=7 vs n=1; 5.6% vs 0.5%).

Image: PD

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: gender dysphoriapuberty suppressiontransgender health
Previous Post

Wellness Check: Exercise

Next Post

Incidence and predictors of multimorbidity in a Korean geriatric population

RelatedReports

Rapid growth of medical artificial intelligence technology usage identified from insurance claims analysis, yet major barriers to widespread adoption remain
Endocrinology

Adolescents and their caregivers report benefits, challenges, and recommendations regarding gender-affirming care in primary care

September 12, 2023
2MM Podcast

The 2 Minute Medicine Podcast Episode 8

February 9, 2023
Mental health parity law associated with financial protection for children
Endocrinology

Gender-affirming hormones improve psychosocial functioning in transgender youth

January 31, 2023
Parental nonmedical prescription opioid use linked to adolescent use
Endocrinology

Gonadotropin releasing hormone analogues use not associated with increased subsequent gender affirming hormone use

November 9, 2022
Next Post
Poor olfaction linked to increased mortality in older adults

Incidence and predictors of multimorbidity in a Korean geriatric population

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]

The COVE trial: mRNA-1273 vaccine for preventing COVID-19 [Classics Series]

The ABCD2 score: Risk of stroke after Transient Ischemic Attack (TIA) [Classics Series]

The EMPACTA trial: Tocilizumab reduced COVID-19 disease-related adverse health outcomes [Classics Series]

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early screening for emotional and cognitive issues may improve psychiatric outcomes for stroke patients
  • Artificial intelligence may assist in early detection of decreased ejection fraction on echocardiograms
  • #VisualAbstract: Tarlatamab Improves Survival in Small-Cell Lung Cancer after Platinum-Based Chemotherapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.